Home / Import refusals / AEK-2587483-3/11/1

FDA Import Refusal AEK-2587483-3/11/1 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company — FEI 2650089

The FDA refused shipment AEK-2587483-3/11/1 from Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company (United States) on Jan 12, 2023. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jan 12, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
61LCE44 APIXABAN (ANTI-COAGULANT)
Charges
75

Recent inspections

Compliance actions

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.